Market News & Trends
BioNTech Completes Acquisition of Biotheus
BioNTech SE recently announced the completion of the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of novel antibodies to…
Purple Biotech Announces Research Collaboration With the Icahn School of Medicine at Mount Sinai
Purple Biotech Ltd. recently announced it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai (Icahn School of…
HCW Biologics Granted FDA Clearance to Evaluate One of its Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
HCW Biologics Inc. recently announced it has received clearance of its Investigational New Drug Application (IND) from the US FDA to initiate a first-in-human Phase…
Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-Initiated Phase 1/2 Clinical Trial Using Seclidemstat With Azacitidine to Treat Hematologic Cancers
Salarius Pharmaceuticals, Inc. recently announced patient enrollment will resume in the investigator-initiated Phase 1/2 clinical trial evaluating seclidemstat in combination with azacitidine for the treatment…
Jupiter Neurosciences Announces Manufacturing Agreement With Catalent
Jupiter Neurosciences, Inc. recently announced it has entered into an agreement with Catalent Pharma Solutions, LLC for the production of JOTROL softgel capsules to support…
Nuvation Bio Announces Expanded Access Program in the US for Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc. recently announced it has initiated an Expanded Access Program (EAP) for taletrectinib in the US for the treatment of patients with locally…
SGS Introduces First Commercial Cell Sorting Service for the Biopharmaceutical Industry
SGS, the world’s leading testing, inspection and certification company, is proud to announce the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell…
Jupiter Neurosciences Partners With Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
Jupiter Neurosciences, Inc. recently announced a strategic partnership with Zina Biopharmaceuticals, LLC to support all aspects of Jupiter’s upcoming Phase 2a clinical trial for Parkinson’s…
Rentschler Biopharma Announces Strategic Realignment of its Global Business Operations
Rentschler Biopharma SE recently announced a realignment of its global business operations as part of a long-term strategic shift. As part of this realignment, Rentschler…
Northstrive Biosciences Signs Agreement for a Potential Breakthrough Obesity Therapy Targeting Fat Loss & Muscle Preservation in Combination With GLP-1
PMGC Holdings Inc. (formerly Elevai Labs Inc.) recently announced that its subsidiary, Northstrive Biosciences Inc., has executed a research agreement with a leading preclinical contract…
Ocean Biomedical Advances Malaria Vaccine Research With New NIH Funding & Expedited Development Pathway
Ocean Biomedical recently announced its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant funding from the National Institutes…
Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure
Sapio Sciences recently announced Schrödinger has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By…
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the U.S. Food and…
Silexion Therapeutics Reports Strong Tumor Growth Reduction From Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced promising new…
Upperton Completes Build of New Sterile Manufacturing Facility
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The…
Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio With Issuance of Patent for Platform Technology
Sonnet BioTherapeutics Holdings, Inc recently announced that the European Patent Office (EPO) has granted Patent No. EP3583125 B1, titled Albumin Binding Domain Fusion Proteins, which covers…
Nemera Awarded EcoVadis Gold Medal: A Recognition of its Commitment to Sustainable Development
Having been awarded the silver medal since 2020, Nemera has reached a significant milestone in 2024 by obtaining the EcoVadis gold medal, with a score…
Alvotech & Teva Announce Filing Acceptance of US Biologics License Applications for a Proposed Biosimilar to Simponi & Simponi Aria
Alvotech and Teva Pharmaceuticals recently announced the US FDA has accepted for review Biologics License Applications (BLA) for AVT05, Alvotech’s proposed biosimilar to Simponi and…
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of Second-Generation TriKE for the Treatment of Hematologic Malignancies
GT Biopharma, Inc. recently announced the first patient was dosed in a Phase 1 trial evaluating GTB-3650, its second-generation TriKE, for the treatment of relapsed…
US Patent Office Granted Can-Fite Namodenoson Patent for Use as Anti-Obesity Drug
Can-Fite BioPharma Ltd. recently announced its lead drug candidate Namodenoson was granted a patent for its use as an anti-obesity drug by the US patent…